Doris-Ann Williams MBE, CEO of BIVDA presented to MPs at the latest meeting of the Parliamentary and Scientific Committee, which focused on life sciences in the UK. Welcomed to the meeting by Chair, Andrew Miller MP, Doris-Ann was joined by Professor Guy Poppy, Chief Scientific Adviser at the Food Standards Agency, and Dr Malcolm Skingle CBE, Director, Academic Liaison, GlaxoSmithKline.
NICE have issued two draft guidelines on diabetes care. Of the two documents, one focuses on adults with type 1 diabetes and the other concentrates on children and young adults, with both type 1 or type 2.
For more information, click below.
Antimicrobial Resistance has been a hot topic in the news again this week, as two reports have been released. To find out more, click below.
Today (27 November, 2014) a commission established by the Lancet has reported that liver disease stands out as a glaring exception to the vast improvements made during the past 30 years in health and life expectancy for chronic disorders such as stroke, heart disease and many cancers.
Today is European Antibiotics Awareness Day 2014 (EAAD). This International Day of awareness was started in order to educate people about the appropriate use of antibiotics, in the fight against Antimicrobial Resistance (AMR).
With the 2015 General Election fast approaching, BIVDA co-hosted three discussion meetings at the Labour, Conservative and Liberal Democrat Party conferences, as part of Life Science UK, and with the AMRC.
Today is Testing Tuesday! And this week we are raising awareness of Hepatitis. (Not heard of TestingTuesday? See here to find out more)
Following four years in office, with a solid reputation for representing the scientific community, as well as British universities, David Willetts MP has moved on as Minister for Universities and Science. The work he has undertaken will of course be remembered, and we are still looking forward to working on the Catapult for Precision Medicine brought about by David Willetts.
The dual role of David “two brains” Willetts has been taken on by two MPs, George Freeman and Greg Clark.
Prime Minister David Cameron, has announced a review into antimicrobial resistance, and why so few drugs have been manufactured in recent years. The last major antibiotic was created in 1987.
Jim O’Neill, former Chief Economist at Goldman Sachs, will lead a global panel of experts from science, finance, industry, and global health, aiming to spur the development of a “new generation of antibiotics”. Work will begin in September, with the first £500,000 of the project being funded by the Wellcome Trust. Mr O’Neill is expected to deliver his recommendations next spring.
Today NICE will publish updated guidance on the treatment of Atrial Fibrillation. Although NICE periodically updates all of its guidance to take account of the latest research and best practice, for the first time today the guidance will be accompanied by the publication of a Consensus statement on the use of Novel Oral Anticoagulants (NOACs) drafted by the NICE Implementation Collaborative (NIC). BIVDA has been a member of the NIC Board since its inception as part ofInnovation, Health and Wealth.